Paired associate performance in the early detection of DAT
- PMID: 11843075
Paired associate performance in the early detection of DAT
Abstract
Subjects underwent longitudinal neuropsychological assessment in order to retrospectively determine which measures of cognitive function best predicted later development of dementia of the Alzheimer type (DAT). Three groups of subjects were studied: normal controls, patients with early DAT, and questionable dementia subjects (QD). All subjects were assessed using a battery of standard neuropsychological measures and two subtests from the Cambridge Neuropsychological Test Automated Battery (CANTAB), paired associate learning and delayed matching to sample. A structured interview was also used to elicit a profile of the subject's daily functioning. Subjects were assessed every 6 months for 2 years. At the 6 month assessment, almost half of the QD group exhibited significant deterioration in scores on the computerized paired associate learning subtest, while maintaining their scores on standard measures. At the conclusion of the study, all of this QD subgroup fulfilled the NINCDS-ADRDA criteria for probable DAT pertaining to significant cognitive and functional deterioration. Performance on the C
Similar articles
-
Computerized neuropsychological tests in the early detection of dementia: prospective findings.J Int Neuropsychol Soc. 1997 Mar;3(2):139-46. J Int Neuropsychol Soc. 1997. PMID: 9126855
-
Neuropsychological markers of dementia in patients with memory complaints.Int J Geriatr Psychiatry. 2004 Apr;19(4):352-8. doi: 10.1002/gps.1074. Int J Geriatr Psychiatry. 2004. PMID: 15065228
-
Subjective complaints and self-evaluation of memory test performance in Questionable dementia.Int J Geriatr Psychiatry. 2006 Oct;21(10):937-44. doi: 10.1002/gps.1586. Int J Geriatr Psychiatry. 2006. PMID: 16927400
-
Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.Int J Geriatr Psychiatry. 2003 Nov;18(11):1021-8. doi: 10.1002/gps.1010. Int J Geriatr Psychiatry. 2003. PMID: 14618554
-
Toward a definite diagnosis of Alzheimer's disease.Compr Psychiatry. 1992 Jul-Aug;33(4):282-90. doi: 10.1016/0010-440x(92)90054-t. Compr Psychiatry. 1992. PMID: 1643871 Review.
Cited by
-
Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats.Front Pharmacol. 2022 Feb 14;13:820210. doi: 10.3389/fphar.2022.820210. eCollection 2022. Front Pharmacol. 2022. PMID: 35250569 Free PMC article.
-
Source recognition discriminability impairment in Huntington's versus Alzheimer's disease: Evidence from the CVLT-3.Appl Neuropsychol Adult. 2024 Nov-Dec;31(6):1163-1168. doi: 10.1080/23279095.2022.2112682. Epub 2022 Aug 19. Appl Neuropsychol Adult. 2024. PMID: 35984776
-
Sodium selenate as a disease-modifying treatment for mild-moderate Alzheimer's disease: an open-label extension study.BMJ Neurol Open. 2021 Dec 16;3(2):e000223. doi: 10.1136/bmjno-2021-000223. eCollection 2021. BMJ Neurol Open. 2021. PMID: 34988458 Free PMC article.
-
Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome.Disabil Health J. 2018 Jul;11(3):486-490. doi: 10.1016/j.dhjo.2018.02.003. Epub 2018 Feb 26. Disabil Health J. 2018. PMID: 29501470 Free PMC article. Clinical Trial.
-
Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment.J Int Neuropsychol Soc. 2012 Sep;18(5):886-97. doi: 10.1017/S1355617712000689. Epub 2012 May 24. J Int Neuropsychol Soc. 2012. PMID: 22622022 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical